The comparison of outcome and cost of three protocols for childhood non-high risk acute lymphoblastic leukemia in China

Pediatric Blood and Cancer

Volumn 51, Issue 2, 2008, Pages 204-209

  Luo, Xue Qun ^a   Ke, Zhi Yong ^a   Guan, Xiao Qing ^a   Zhang, Ying Chuang ^a   Huang, Li Bin ^a   Zhu, Jia ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Childhood acute lymphoblastic leukemia; Developing country; Long term outcome; Treatment cost

Indexed keywords

ASPARAGINASE; CETUXIMAB; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; PREDNISONE; VINCRISTINE; ANTINEOPLASTIC AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; CHINA; CLINICAL PROTOCOL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DISEASE FREE SURVIVAL; FEASIBILITY STUDY; FEMALE; HEALTH CARE COST; HIGH RISK PATIENT; HOSPITAL COST; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; PATIENT TRANSPORT; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; HOSPITALIZATION; INFANT; LYMPHATIC LEUKEMIA; MORTALITY; PRESCHOOL CHILD; SEPSIS;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; FEMALE; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; INFANT; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SEPSIS; TREATMENT OUTCOME;

EID: 45549104957     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21598     Document Type: Article

References (16)

1. Metzger ML, Howard SC, Fu LC, et al. Outcome of childhood acute lymphoblastic leukemia in resource-poor countries. Lancet 2003;362:706-708.
2. Mostert S, Sitaresmi MN, Gundy CM, et al. Influence of socioeconomic status on childhood acute lymphoblastic leukemia treatment in Indonesia. Pediatrics 2006;118:1600-1606.
3. Tang JY, Xue HL, Gu LJ, et al. Failure of treatment and protocol compliance in patients with acute lymphoblastic leukemia. Chin J Pediatr 2005;43:490-493.
4. Matloub Y, Lindemulder S, Gaynon PS, et al. Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: Results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children's Oncology Group. Blood 2006;108:1165-1173.
5. Kamps WA, Veerman AJP, Wering ERV, et al. Long-term follow-up of Dutch Childhood Leukemia Study Group (DCLSG) protocols for children with acute lymphoblatic leukemia, 1984-1991. Leukemia 2000;14:2240-2246.
6. Arico M, Conter Y, Valsecchi MG, et al. Treatment reduction in highly selected standard-risk childhood acute lymphoblastic leukemia. The AIEO ALL-9501 study. Haematologica 2005;90:1186-1191.
7. Peto R, Peto J. Asymptotically efficient rank invariant test procedures. J R Stat Soc (A) 1972;135-206.
8. Gu LJ, Li J, Xue HL, et al. Analysis of therapeutic effectiveness in 158 childhood acute lymphoblastic leukemia patients treated with ALL-XH-99 protocol. Chin J Hematol 2004;25:1-4.
9. Yu J, Xu YH, Xian Y, et al. Clinical study on childhood acute lymphoblastic leukemia treated with Rongcheng 98 Protocol. Chin J Pract Pediatr 2005;20:158-160.
10. Dabbous IA, Dbouk H, Sibai AM, et al. Childhood acute lymphoblastic leukemia managed in tertiary care center in a developing country. Med Pediatr Oncol 2003;41:83-84.
11. Howard SC, Pedrosa M, Lins M, et al. Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukemia in a resource-poor area. JAMA 2004;291:2471-2475.
12. Miakova NV, Hartmann R, Rudneva AE, et al. Results of treatment of childhood acute lymphoblastic leukemia according to the Berlin-Moscow-91 protocol in1991-2000. Vopr Onkol 2002;48:340-346.
13. von Stackelberg A, Karatchunsky A, Kudrjashova J, et al. Toxicity, supportive care and costs of two chemotherapy protocols for treatment of childhood ALL in Russia: BFM 90m and MB 91. Eur J Cancer 1999;35:1349-1355.
14. Howard SC, Ortiz R, Baez LF, et al. Protocol-based treatment for children with cancer in low income countries in Latin America: A report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO)-Part II. Pediatr Blood Cancer 2007;48:486-490.
15. Schrappe M, Reiter A, Ludwig WD, et al. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: Results of trial ALL-BFM 90. Blood 2000;95:3310-3322.
16. Smith M, Arthur D, Camtta B, et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol 1996;14:18-24.